Tumor Biology

, Volume 37, Issue 5, pp 5657–5661 | Cite as

ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers

  • Zheng Li
  • Xin Yu
  • Jianxiong Shen


Long non-coding RNAs (lncRNAs) are a family of non-protein-coding RNAs with length more than 200 nucleotides. LncRNAs played important roles in many biological processes such as cell development, proliferation, invasion and migration. Deregulation of LncRNAs was found in multiple tumors where they can act as a tumor suppressor gene or oncogene. LncRNA ANRIL was identified as an oncogene involved in a number of tumors such as gastric cancer, lung cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma. Inhibition of ANRIL suppressed the cancer cell proliferation, migration and invasion. Increasing data has showed that ANRIL may act as a diagnostic and prognostic biomarker for some tumors. In our review, we summarize an overview of current knowledge concerning the expression and role of ANRIL in various cancers.


Long non-coding RNAs lncRNAs ANRIL Cancer 



This work was supported by grants from the National Natural Science Foundation of China (NSFC) (Grant Numbers: 81401847, 81272053 and 81330044).

Compliance with ethical standards

Conflicts of interest



  1. 1.
    Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, et al. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol. 2015;36:521–32.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012;3:219.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45:1895–910.CrossRefPubMedGoogle Scholar
  5. 5.
    Kitagawa M, Kotake Y, Ohhata T. Long non-coding RNAs involved in cancer development and cell fate determination. Curr Drug Targets. 2012;13:1616–21.CrossRefPubMedGoogle Scholar
  6. 6.
    Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703–19.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Taylor DH, Chu ET, Spektor R, Soloway PD. Long non-coding RNA regulation of reproduction and development. Mol Reprod Dev. 2015. doi: 10.1002/mrd.22581.
  8. 8.
    Yang Y, Wen L, Zhu H. Unveiling the hidden function of long non-coding RNA by identifying its major partner-protein. Cell Biosci. 2015;5:59.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Yu X, Li Z. The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med. 2015. doi: 10.1111/jcmm.12649.
  10. 10.
    Li Z, Yu X, Shen J. The role of miRNAs in the pheochromocytomas. Tumour Biol. 2015. doi: 10.1007/s13277-015-4199-z.
  11. 11.
    Yu X, Li Z. MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma. J Cell Mol Med. 2015. doi: 10.1111/jcmm.12650.
  12. 12.
    Li Z, Yu X, Shen J, Jiang Y. MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget. 2015;6:4562–8.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Yu X, Li Z. Long non-coding RNA growth arrest-specific transcript 5 in tumor biology. Oncol Lett. 2015;10:1953–8.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Yu X, Li Z. Long non-coding RNA HOTAIR: a novel oncogene (review). Mol Med Rep. 2015;12:5611–8.PubMedGoogle Scholar
  15. 15.
    Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers. 2015;7:2169–82.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wang G, Liu C, Deng S, Zhao Q, Li T, Qiao S, et al. Long noncoding rnas in regulation of human breast cancer. Brief Funct Genomics. 2015. doi: 10.1093/bfgp/elv049.
  17. 17.
    Tao H, Yang JJ, Zhou X, Deng ZY, Shi KH, Li J. Emerging role of long non-coding RNAs in lung cancer: current status and future prospects. Respir Med. 2015;110:12–9. Google Scholar
  18. 18.
    Meseure D, Drak Alsibai K, Nicolas A, Bieche I, Morillon A. Long non-coding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets. Biomed Res Int. 2015;2015:320214.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shahryari A, Jazi MS, Samaei NM, Mowla SJ. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet. 2015;6:196.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ding X, Wan X, Jiang H, Song H, Fang Y, Chen S, et al. The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses. Tumour Biol. 2015;36:4017–25.CrossRefPubMedGoogle Scholar
  21. 21.
    Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015;12:1–9.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang B, et al. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett. 2015;360:119–24.CrossRefPubMedGoogle Scholar
  23. 23.
    Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long non-coding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65:1140–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Yarmishyn AA, Kurochkin IV. Long non-coding RNAs: a potential novel class of cancer biomarkers. Front Genet. 2015;6:145.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget. 2014;5:10976–96.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense non-coding RNA whose expression coclusters with ARF. Cancer Res. 2007;67:3963–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, et al. Long non-coding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of mir-99a/mir-449a. Oncotarget. 2014;5:2276–92.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A, et al. Expression analysis of four long non-coding RNAs in breast cancer. Tumour Biol. 2015. doi: 10.1007/s13277-015-4135-2.
  29. 29.
    Naemura M, Murasaki C, Inoue Y, Okamoto H, Kotake Y. Long non-coding RNA ANRIL regulates proliferation of non-small-cell lung cancer and cervical cancer cells. Anticancer Res. 2015;35:5377–82.PubMedGoogle Scholar
  30. 30.
    Zhu H, Li X, Song Y, Zhang P, Xiao Y, Xing Y. Long non-coding RNA ANRIL is upregulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun. 2015;467:223–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Kia SK, Gorski MM, Giannakopoulos S, Verrijzer CP. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol. 2008;28:3457–64.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol. 2006;7:667–77.CrossRefPubMedGoogle Scholar
  33. 33.
    Ozenne P, Eymin B, Brambilla E, Gazzeri S. The ARF tumor suppressor: structure, functions and status in cancer. Int J Cancer. 2010;127:2239–47.CrossRefPubMedGoogle Scholar
  34. 34.
    Kheradmand Kia S, Solaimani Kartalaei P, Farahbakhshian E, Pourfarzad F, von Lindern M, Verrijzer CP. EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. Epigenetics Chromatin. 2009;2:16.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the non-coding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010;38:662–74.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Aguilo F, Di Cecilia S, Walsh MJ. Long non-coding RNA ANRIL and polycomb in human cancers and cardiovascular disease. Curr Top Microbiol Immunol. 2015. doi: 10.1007/82_2015_455.
  37. 37.
    He S, Gu W, Li Y, Zhu H. ANRIL/CDKN2B-AS shows two-stage clade-specific evolution and becomes conserved after transposon insertions in simians. BMC Evol Biol. 2013;13:247.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Aguilo F, Zhou MM, Walsh MJ. Long non-coding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 2011;71:5365–9.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4b) tumor suppressor gene. Oncogene. 2011;30:1956–62.CrossRefPubMedGoogle Scholar
  40. 40.
    Rodriguez C, Borgel J, Court F, Cathala G, Forne T, Piette J. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus. Biochem Biophys Res Commun. 2010;392:129–34.CrossRefPubMedGoogle Scholar
  41. 41.
    Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, et al. Long non-coding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and p21 expression. Mol Cancer Ther. 2015;14:268–77.CrossRefPubMedGoogle Scholar
  42. 42.
    Lin L, Gu ZT, Chen WH, Cao KJ. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn Pathol. 2015;10:14.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kang YH, Kim D, Jin EJ. Down-regulation of phospholipase d stimulates death of lung cancer cells involving upregulation of the long ncRNA anril. Anticancer Res. 2015;35:2795–803.PubMedGoogle Scholar
  44. 44.
    Huang MD, Chen WM, Qi FZ, Xia R, Sun M, Xu TP, et al. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of klf2. J Hematol Oncol. 2015;8:50.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Hua L, Wang CY, Yao KH, Chen JT, Zhang JJ, Ma WL. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8:3076–82.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin Y, et al. ANRIL inhibits p15(INK4b) through the TGF beta 1 signaling pathway in human esophageal squamous cell carcinoma. Cell Immunol. 2014;289:91–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Kang M, Sang Y, Gu H, Zheng L, Wang L, Liu C, et al. Long non-coding RNAs POLR2Ee rs3787016 c/t and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer. Tumour Biol. 2015;36:6401–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Martinez-Fernandez M, Feber A, Duenas M, Segovia C, Rubio C, Fernandez M, et al. Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer. Clin Epigenetics. 2015;7:109.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY, Hua KQ. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. Int J Oncol. 2015;46:2497–505.PubMedGoogle Scholar
  50. 50.
    Iacobucci I, Sazzini M, Garagnani P, Ferrari A, Boattini A, Lonetti A, et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res. 2011;35:1052–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, et al. Role of non-coding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst. 2011;103:1713–22.CrossRefPubMedGoogle Scholar
  52. 52.
    Mussotter T, Kluwe L, Hogel J, Nguyen R, Cooper DN, Mautner VF, et al. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. BMC Med Genet. 2012;13:98.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  1. 1.Department of Orthopedic SurgeryPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  2. 2.Department of DermatologyPeking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeBeijingChina

Personalised recommendations